🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 604749101
- Market Cap
- Mid Cap
- IPO
- 7/18/2019 · $15.00/share
Business: Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).
Company Contact
- CEO
- Christopher Peetz
- CFO
- Eric Bjerkholt
- Headquarters
- 989 East Hillsdale Boulevard, Suite 300 Foster City, CA 94404
- Phone
- 650-667-4085
- Investor Relations
- Andrew McKibben · 650-667-4085 · ir@mirumpharma.com